At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 24, 2026 at 19:00 ET
Seven executives at Vertex Pharmaceuticals sold shares in a coordinated cluster over a 3-day window, with total open-market sales amounting to $4.4 million. All transactions were direct sales at market prices, including a $1.2 million sale by the Chief Commercial Officer. The activity represents less than 0.01% of the company's $123.5B market cap and aligns with routine insider selling patterns.
- 8 open-market share sales by 8 different insiders over 7 days
- Total value of sales: $4,453,244.64
- All sellers are C-suite executives, including EVPs across commercial, legal, scientific, technical, and medical functions
- No purchases, grants, or derivative exercises in the cluster
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access